IMPACT OF ETRASIMOD ON BLOOD PRESSURE AND HYPERTENSION: DATA FROM THE ETRASIMOD ULCERATIVE COLITIS CLINICAL PROGRAMME

Severine Vermeire  ¹     David T. Rubin  ²     Laurent Peyrin-Biroulet  ^{3, 4}     Marla C. Dubinsky  ⁵     Miguel Regueiro  ⁶     Peter Irving  ⁷     Martina Goetsch  ⁸     Krisztina Lazin  ⁸     Joseph Wu  ⁹     Irene Modesto  ¹⁰     John C. Woolcott  ¹¹     Aoibhinn McDonnell  ¹²     Chris Rabbat  ¹³     Andres Yarur  ^14    
1 University Hospital Leuven, Leuven, Belgium
² University of Chicago Medicine Inflammatory Bowel Disease Center, Chicago, United States
³ University of Lorraine, CHRU-Nancy, Nancy, France
⁴ University of Lorraine, Inserm, NGERE, Nancy, France
⁵ Icahn School of Medicine at Mount Sinai, New York, United States
⁶ Cleveland Clinic, Cleveland, United States
⁷ Guy´s and St Thomas´ Hospital, London, United Kingdom
⁸ Pfizer AG, Zürich, Switzerland
⁹ Pfizer Inc, Groton, United States
¹⁰ Pfizer Inc, Madrid, Spain
¹¹ Pfizer Inc, Collegeville, United States
¹² Pfizer Ltd, Sandwich, Kent, United Kingdom
¹³ Pfizer Inc, New York, United States
¹⁴ Cedars-Sinai Medical Center, Los Angeles, United States

Topic
IBD

Session
PP 05 IBD (Posters)

Conference
UEG Week 2023

Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)